TY - JOUR
T1 - Executive dysfunction and the course of geriatric depression
AU - Alexopoulos, George S.
AU - Kiosses, Dimitris N.
AU - Heo, Moonseong
AU - Murphy, Christopher F.
AU - Shanmugham, Bindu
AU - Gunning-Dixon, Faith
N1 - Funding Information:
This work was supported by National Institute of Mental Health grants RO1 MH65653, RO1 MH42819, RO1 MH51842, and P30 MH68638, Forest Pharmaceuticals, the Sanchez Foundation, and Dr. I Foundation (GSA). GSA received research grants by Forest Pharmaceuticals and Cephalon and participated in scientific advisory board meetings of Forest Pharmaceuticals. He has given lectures supported by Forest, Cephalon, Bristol Meyers, Janssen, Pfizer, and Lilly and has received support by Comprehensive Neuroscience for the development of treatment guidelines in late-life psychiatric disorders.
PY - 2005/8/1
Y1 - 2005/8/1
N2 - Background: Executive dysfunction is common in geriatric depression and persists after improvement of depressive symptoms. This study examined the relationship of executive impairment to the course of depressive symptoms among elderly patients with major depression. Methods: A total of 112 nondemented elderly patients with major depression participated in an 8-week citalopram trial at a target daily dose of 40 mg. Executive functions were assessed with the initiation/perseveration subscale of the Dementia Rating Scale and the Stroop Color-Word test. Medical burden was rated with the Cumulative Illness Rating Scale. Results: Both abnormal initiation/perseveration and abnormal Stroop Color-Word scores were associated with an unfavorable response of geriatric depression to citalopram. In particular, initiation/perseveration scores below the median (≤35) and Stroop scores at the lowest quartile (≤22) predicted limited change in depressive symptoms. Impairment in other Dementia Rating Scale cognitive domains did not significantly influence the outcome of depression. Conclusions: Executive dysfunction increases the risk for poor response of geriatric depression to citalopram. Because executive functions require frontostriatal-limbic integrity, this observation provides the rationale for investigation of the role of specific frontostriatal-limbic pathways in perpetuating geriatric depression. Depressed elderly patients with executive dysfunction require vigilant clinical attention because they might be at risk to fail treatment with a selective serotonin reuptake inhibiting antidepressant.
AB - Background: Executive dysfunction is common in geriatric depression and persists after improvement of depressive symptoms. This study examined the relationship of executive impairment to the course of depressive symptoms among elderly patients with major depression. Methods: A total of 112 nondemented elderly patients with major depression participated in an 8-week citalopram trial at a target daily dose of 40 mg. Executive functions were assessed with the initiation/perseveration subscale of the Dementia Rating Scale and the Stroop Color-Word test. Medical burden was rated with the Cumulative Illness Rating Scale. Results: Both abnormal initiation/perseveration and abnormal Stroop Color-Word scores were associated with an unfavorable response of geriatric depression to citalopram. In particular, initiation/perseveration scores below the median (≤35) and Stroop scores at the lowest quartile (≤22) predicted limited change in depressive symptoms. Impairment in other Dementia Rating Scale cognitive domains did not significantly influence the outcome of depression. Conclusions: Executive dysfunction increases the risk for poor response of geriatric depression to citalopram. Because executive functions require frontostriatal-limbic integrity, this observation provides the rationale for investigation of the role of specific frontostriatal-limbic pathways in perpetuating geriatric depression. Depressed elderly patients with executive dysfunction require vigilant clinical attention because they might be at risk to fail treatment with a selective serotonin reuptake inhibiting antidepressant.
KW - Executive dysfunction
KW - Geriatric depression
KW - Treatment outcome
UR - http://www.scopus.com/inward/record.url?scp=23444441630&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=23444441630&partnerID=8YFLogxK
U2 - 10.1016/j.biopsych.2005.04.024
DO - 10.1016/j.biopsych.2005.04.024
M3 - Article
C2 - 16018984
AN - SCOPUS:23444441630
SN - 0006-3223
VL - 58
SP - 204
EP - 210
JO - Biological Psychiatry
JF - Biological Psychiatry
IS - 3
ER -